A new Australian bio-technology company secures a licence to develop a drug to block the development of metastatic prostate cancer. Filamon Limited, an Australian drug
An Australian biotech is hoping for success with its attempt to turn a virus into a cancer fighter after its first patient was dosed in
ABA Legal Group is seeing significant growth in its Bioscience Unit as it plans to capitalise on renewed government and investor focus on Australia’s local